Probuphine implants provided continuous steady state delivery of buprenorphine PLX3397 research buy until their removal at 6 months. Withdrawal symptoms and craving remained low throughout the 6 months. For the 12 subjects, an average of 59% of urines were opioid-negative across the 6 month treatment period. Injection site reactions were present in half of patients, but none were serious. No safety concerns were evident. These results suggest that Probuphine implants offer significant promise for enhancing delivery of effective opioid substitution treatment while minimizing risk for abuse of medication. (C) 2009 Elsevier
Ireland Ltd. All rights reserved.”
“Background: Peripheral endothelial dysfunction (ED) has been found in patients with severe heart failure. Whether ED improves after heart transplantation (HTx) is still a matter of controversy.
Methods: Forearm endothelium-dependent vasoreactivity was assessed in 40 patients after HTx. Flow-mediated vasodilatation (FMD) was measured by high-resolution brachial artery ultrasound to assess endothelial function at 1, 6, and 12 months after HTx. Cardiac allograft vasculopathy (CAV) was assessed by coronary angiography at 1 and Belinostat 12 months and by intravascular ultrasound (IVUS) at. 1 year.
Results: Mean FMD at 1 month was 1.9% +/- 2.6%, improving to 3.3% +/- 3.2% at 6 months (P < 0.005) and to 5.1% +/- 3.4% at 1 year (p < 0.0001). FMD was significantly impaired
in 33 patients (829’0) at 1 month, in 27 (67%) find more at 6 months, and in 19 (47%) at 1 year after HTx. CAV was diagnosed by IVUS in 19 patients
(63%) at 1 year. Patients without peripheral ED at 1 month had lower incidence of increased intimal thickness of 0.5 mm or more at 1 year after HTx (20% vs 75%, P < 0.01).
Conclusions: Impairment of peripheral FMD was highly prevalent soon after HTx and was present in nearly 50% of patients at 1 year. Patients without peripheral ED at 1 month were associated with lower probability of CAV. Although more studies are needed, the evaluation of peripheral endothelial function at 1 month after HTx could be potentially useful to identify patients at lower risk of CAV. J Heart Lung Transplant 2009;28:299-304. Copyright (C) 2009 by the International Society for Heart and Lung Transplantation.”
“Objective-To evaluate recipes of diets recommended for animals with chronic kidney disease (CKD), compare nutritional profiles for those recipes to requirements for adult dogs and cats, and assess their appropriateness for the management of CKD.
Design-Evaluation study.
Sample-Recipes of 67 home-prepared diets promoted for use in dogs (n = 39 recipes) and cats (28) with CKD.
Procedures-Recipes were analyzed with computer software to determine calories, macronutrient calorie distribution, and micronutrient concentrations and were assessed for appropriateness for the management of CKD.